Therapeutic Application of Intrabodies Against Age-Related Neurodegenerative Disorders
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
6028-6036
Author(s):
Alessio Cardinale, Daniela Merlo, Paolo Giunchedi and Silvia Biocca
A Systems Medicine Clinical Platform for Understanding and Managing Non- Communicable Diseases
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
5945-5956
Author(s):
Paolo Maria Rossini, Achille Lococo, Dieter Maier, Frederick Marcus, Stefano Margaritora, Camillo Marra, Gianfranco Minati, Monica Neri, Franco Pasqua, Christophe Pison, Christian Pristipino, Joseph Roca, Giuseppe Rosano, Filippo Lococo, Patrizia Russo, Gianluca Salinaro, Shani Shenhar, Hermona Soreq, Peter J. Sterk, Fabrizio Stocchi, Margherita Torti, Maurizio Volterrani, Emiel F.M. Wouters, Alessandra Frustaci, Stefano Bonassi, Nikolai Daraselia, Charles Auffray, Alvar Agusti, Giovanni Apolone, Rudi Balling, Piero Barbanti, Alfonso Bellia, Stefania Boccia, Jean Bousquet, Vittorio Cardaci, Mario Cazzola, Valentina Dall'Armi, Alfredo Cesario, Lucio Da Ros, Alessandra Del Bufalo, Giuseppe Ducci, Luigi Ferri, Massimo Fini, Chiara Fossati, Gianfranco Gensini, Pierluigi Maria Granone, James Kinross, Davide Lauro and Gerland Lo Cascio
Editorial (Thematic Issue: Disease Control and Active and Healthy Ageing: New Paradigms of Therapeutic Strategy)
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
5919-5920
Author(s):
Patrizia Russo, Massimo Fini and Alfredo Cesario
Activated Immune System and Inflammation in Healthy Ageing: Relevance for Tryptophan and Neopterin Metabolism
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
6048-6057
Author(s):
Lucile Capuron, Simon Geisler, Katharina Kurz, Friedrich Leblhuber, Barbara Sperner-Unterweger and Dietmar Fuchs
PET Radioligands for In Vivo Visualization of Neuroinflammation
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
5897-5913
Author(s):
Dieter Ory, Sofie Celen, Alfons Verbruggen and Guy Bormans
Interactions Between Apo E and Amyloid Beta and their Relationship to Nutriproteomics and Neurodegeneration
Journal:
Current Proteomics
Volume:
11
Page:
171-183
Author(s):
Ian J. Martins, Veer Gupta, Andrea C. Wilson, Stephanie J. Fuller and Ralph N. Martins
Biomarkers and Future Targets for Development in Amyotrophic Lateral Sclerosis
Journal:
Current Medicinal Chemistry
Volume:
21
Page:
3535-3550
Author(s):
Parvathi Menon, Matthew C. Kiernan and Steve Vucic
Therapeutic Targeting of Epigenetic Components in Amyotrophic Lateral Sclerosis (ALS)
Journal:
Current Medicinal Chemistry
Volume:
21
Page:
3576-3582
Author(s):
J. Lee, H. Ryu, G. Keum, Y.J. Yoon, N.W. Kowall and H. Ryu
Potential Therapeutic Drugs and Methods for the Treatment of Amyotrophic Lateral Sclerosis
Journal:
Current Medicinal Chemistry
Volume:
21
Page:
3583-3593
Author(s):
G. Yacila and Y. Sari
Cell to Cell Spreading of Misfolded Proteins as a Therapeutic Target in Motor Neuron Disease
Journal:
Current Medicinal Chemistry
Volume:
21
Page:
3508-3534
Author(s):
Livia Pasquali, Paola Lenzi, Francesca Biagioni, Gabriele Siciliano and Francesco Fornai